Send me real-time posts from this site at my email
Forecast came true

Are You Buying Valeant Pharmaceuticals?
16 may

$VRX was a short-sell call call for DIYers in 2015. The stock topped $248 on July, 2015.

Coverage resumed for the Value Stock investor last year and continues. VRX bottomed in the $12-15 range. 

Irina Koffler finally came to her senses and upgraded the stock to a hold. Her record on is here:

Are you buying Valeant stock? 

Agree for YES.

Disagree for NO.

Are You Buying Valeant Pharmaceuticals?

33 people
8 people

Forecast came true

33 Agree 8 Disagree. VRX topped 25 and is back to 22.